1. World Health Organization. Global tuberculosis report 2023. 2023 [cited 2024 Apr 12]. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023
2. Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.;Nyang’wa;Lancet Respir Med,2024
3. Restocking the tuberculosis drug arsenal.;Nuermberger;Nat Med,2024
4. Treatment Action Group. Pipeline report 2023: tuberculosis treatment. 2023 [cited 2024 Apr 12]. https://www.treatmentactiongroup.org/wp-content/uploads/2024/03/pipeline_TB_Treatment_2023_final.pdf
5. World Health Organization. Target regimen profiles for tuberculosis treatment, 2023 update. 2023 [cited 2024 Apr 14]. https://www.who.int/publications/i/item/9789240081512